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Abstract
Study Objective—This report contributes to limited empirical data regarding use of the Copper
T380A intrauterine device among adolescent mothers.
Design—We conducted a retrospective case series of adolescent mothers age 15 to 21 years
whose index delivery occurred before age 18 and met study inclusion criteria.
Setting—All adolescent mothers received obstetrics and gynecology care at one urban clinical
site in Washington, DC.
Participants—Each participated in a teen secondary pregnancy prevention program from April
2002 to November 2008 and used the Copper T380A intrauterine device.
Main outcome measures—We abstracted data to evaluate intrauterine device utilization,
expulsion, removal, and pregnancy diagnosis.
Results—Thirty-nine adolescent mothers met inclusion criteria. Six patients had partial or
complete expulsion (15%; 95% CI 6–29%), and 10 requested removal (26%; 95% CI 14–41%)
within 24 months of placement. Four users (10%; 95% CI 3–23%) became pregnant. Three had an
intrauterine device in place at time of conception, while one became pregnant due to unrecognized
device expulsion.
Conclusions—In this case series, many adolescent mothers discontinued Copper T380A use
within two years of placement. The numbers of patients were too limited to provide stable
estimates of contraceptive effectiveness. Larger comparative studies will further evaluate both
effectiveness and acceptability of this device among teen mothers.
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The intrauterine device (IUD) is a highly effective form of contraception that has not been
recommended for adolescent populations until recently. Prior concerns regarding increased
infection risk and subsequent infertility among younger age groups are unwarranted1, 2. The
World Health Organization and the American College of Obstetricians and Gynecologists
now endorse its use in this group3.
A recent systematic review found only six cohort or case-control studies of IUD use among
adolescents, all published prior to 1998, none of which were among U.S. populations4. Since
then, only three studies have reported findings related to IUD use in an exclusively
adolescent or young adult population. A questionnaire study, case-series report, and small
randomized controlled trial reported on expulsions, continuation, and satisfaction over
varying time periods5–7.
Efficacy trials report a first-year pregnancy rate of 0.5–0.8% across all ages for the Copper
T380A (CuT380A)8. These rates may not be specific to an adolescent age group with overall
higher fecundity. Other studies suggest expulsion rates may be greater in younger IUD
users, particularly for copper-containing devices9. In this retrospective case-series report, we
describe a sample of adolescent mothers whose index delivery occurred before age 18 while
enrolled in a teen parenting program, and who used the CuT380A. We report device
expulsion, removal, pregnancy, and continuation.
Materials and Methods
We reviewed the charts of a sample of adolescent mothers age 15 to 21 years who delivered
prior to age 18 while participating in a teen secondary pregnancy prevention program.
Program records were reviewed to identify all participants between April 1, 2002 and
November 30, 2008 who elected intrauterine contraception. The study was approved by the
Institutional Review Board of MedStar Health Research Institute.
Overall, 316 adolescent mothers participated in a subsequent teen pregnancy prevention
program at one health center. Adolescent mothers who were 21 years or younger at the time
of insertion, had at least one child, and used the Copper T380A intrauterine device met study
inclusion criteria. Thirty-nine eligible patients were identified. Two patients had a second
IUD, resulting in 41 IUD insertions among this sample. All patients had a negative
pregnancy test at time of insertion, and no pregnancies occurred among users within 45 days
of insertion.
Complete expulsion was defined by the IUD completely exiting the uterine cavity, while
partial expulsion was defined as having some part of the IUD remaining in the uterine
cavity. Complete expulsion was confirmed by ultrasound. Partial expulsion was identified
by physical exam and noted by the examining practitioner. Removal of the IUD was
documented by practitioner medical record notation of performing a removal. Pregnancy
was verified by urine pregnancy test and ultrasound confirmation. Time-to-event was based
on the date of insertion documented in the medical record. Univariate and descriptive
analysis was performed using STATA 10 (College Station, TX, USA). Normally distributed
data were represented by means, and non-normally distributed data were represented by
medians.
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Most participants (93%) were Hispanic. Median age of participants was 18 years old at time
of placement (inter-quartile range 18–20). Seventeen percent had been pregnant more than
once, and 21% had more than one child.
Forty-one CuT380A devices were inserted in the 39 adolescent mothers (including the two
reinsertion procedures). All but one device were placed at least six weeks after delivery.
Median time from delivery to IUD placement was 12 months, with a range of 1 to 43
months. Three did not return for follow-up after insertion. All but one patient had a follow-
up visit within six months. Mean time from insertion to first clinical follow-up visit was 1.2
months, excluding one outlier whose first and only known follow-up visit was 47 months
after insertion. No known uterine perforations occurred at the time of insertion. One patient
had severe cramping and pelvic pain at the time of placement; she elected to have the device
removed within six hours.
Six patients experienced partial or complete expulsion (15%; 95% CI 6–29%). Of those,
four were partial and two were complete expulsions. One complete expulsion resulted in
pregnancy. (Table 1) All but one expelled IUD (83%; 95% CI 41–99%) were placed six
weeks or more after childbirth. The median time from childbirth to insertion was 4 months
among users experiencing an expulsion (inter-quartile range 2 to 10 months).
Four users became pregnant (10%; 95% CI 3–23%), 3 of which occurred within one year of
placement. The pregnancies occurred at 3, 4, 9, and 57 months after insertion, and 3 ended
with live births. Among users who had a pregnancy, three occurred with the IUD in the
uterine cavity. (Table 1)
Ten users requested removal of their CuT380A within 24 months of insertion (26%; 95% CI
14–41%). Three desired removal within six months (8%; 95% CI 2–20%) and six requested
removal within one year of placement (15%; 95% CI 6–30%). Patient-specified reasons for
removal were abstracted from the medical record when noted. Seventeen of the nineteen had
a recorded reason for removal. Two specifically removed their IUD because pregnancy was
desired, and subsequent birth control was not initiated. Two others had their IUD removed
with planned insertion of the etonorgestrel implant, and implantation was performed the
same day. Among the remaining thirteen, one or more reasons for removal were noted. Five
noted vaginal spotting or bleeding, two stated their sexual partners were bothered by IUD
strings, and six included cramping as a reason for removal.
Birth control initiated the day of elective removal was also noted for each patient, except the
two who desired pregnancy. Nine received an injection of depomedroxyprogesterone the
day of removal, two had the etonorgestrel implant inserted as planned, five received a
prescription for oral contraceptives or the ethinyl estradiol transdermal patch, and one did
not desire another form of contraception at that time.
Most patients (72%; 95% CI 56–84%) had either complete follow-up data to termination of
CuT380A use (due to expulsion, pregnancy, or elective removal) or 24 months of follow-up.
Eighty-five percent (95% CI 71–94%) had follow-up for at least 12 months post-insertion.
Sixteen users (41%; 95% CI 27–57%) had their CuT380A in place at the time of data
collection. Of those 16, nearly one-third (31%; 95% CI 12–56%) had their CuT380A in
place for over two years. Of the 72% (28/39) patients who had either complete follow-up
data to termination of CuT380A or at 24 months of follow-up, the continuation rate at one
year was 64% (18/28) and at two years was 39% (11/28).
Patchen and Berggren Page 3














The present findings supplement limited existing empirical data to guide counseling and
practice on IUD use among adolescents and young adults. The outcome frequencies in this
study were based on sparse numbers, however, and the confidence intervals around these
proportions were wide, indicating statistical instability. Nevertheless, the higher than
expected number of pregnancies diagnosed with the IUD in the uterine cavity indicates the
need for additional data.
Many adolescent mothers decided to discontinue their CuT380A within two years of
insertion. Discontinuation rates with depo-medroxyprogesterone acetate are also high10. In
health care settings that support access to multiple long-acting reversible contraception
(LARC) methods, the etonogestrel implant may be an attractive alternative.
Among this sample of adolescent mothers, several reasons were reported for elective
removal. Two patients in this sample reported desire to conceive as a reason for removal. As
the median time from delivery to insertion was 12 months, an inter-pregnancy interval of
two years was achieved in these two patients, as well as others whose reason for removal
was not specifically desire to conceive.
Limitations of this study include its retrospective design and small sample size.
Additionally, the follow-up period varied among patients. Nonetheless, this is one of few
studies with a contemporary sample of adolescent mothers using an IUD. Furthermore, 72%
of the sample had either complete follow-up to discontinuation of IUD use or at least 24
months of follow-up.
IUDs represent an important contraceptive option for sexually active women who wish to
avoid pregnancy. Two recent reports examine attitudes among adolescents and young adults
concerning IUD use. Findings suggest IUD knowledge is limited, but their use is viewed
favorably following education, and providers may influence these attitudes11, 12. Pilot data
and a small case-series reported continuation, expulsion, and pregnancy in a combined total
of 29 adolescent CuT380A users5, 6. It appears likely that IUD use will increase among
these younger age groups, and this report contributes to the limited published data among
adolescents.
Our findings suggest that pregnancies among adolescent mothers using IUDs may occur
more frequently than previously reported, and duration of method continuation may be more
limited than desired. Potential users may benefit from counseling regarding other LARC
methods in addition to the IUD, and reasons for elective removal should be considered when
counseling patients on contraceptive options. Larger comparative studies are needed to
evaluate both effectiveness and acceptability of this device in teen mothers.
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Table 1
IUD method failure among 39 CuT380A users
Outcome of method failure n = Percent 95% CI
Expulsion 6 15 6 – 29
 Partial 4 10 3 – 23
 Complete 2* 5 1 – 16
Pregnancy 4 10 3 – 23
 Ectopic 0 0
 IUD in utero 3 8 2 – 20
 IUD not in utero 1* 3 0 – 12
*
One complete expulsion also represents the pregnancy diagnosed with no IUD in utero
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